Medical Care
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Research Report 2025
- Jul 08, 25
- ID: 347440
- Pages: 75
- Figures: 76
- Views: 2
The global market for Gastrointestinal Stromal Tumor Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A method for diagnosing gastrointestinal Stromal Tumor
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor Molecular Diagnostics.
The Gastrointestinal Stromal Tumor Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Stromal Tumor Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Stromal Tumor Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Yin Feng Gene
KingMed
Geneis
Haplox
AmoyDX
Admera
GeneChem
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A method for diagnosing gastrointestinal Stromal Tumor
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor Molecular Diagnostics.
The Gastrointestinal Stromal Tumor Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Stromal Tumor Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Stromal Tumor Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Yin Feng Gene
KingMed
Geneis
Haplox
AmoyDX
Admera
GeneChem
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Trends by Region
2.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue
3.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
3.7 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Yin Feng Gene
11.1.1 Yin Feng Gene Company Details
11.1.2 Yin Feng Gene Business Overview
11.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.1.4 Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.1.5 Yin Feng Gene Recent Development
11.2 KingMed
11.2.1 KingMed Company Details
11.2.2 KingMed Business Overview
11.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.2.4 KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.2.5 KingMed Recent Development
11.3 Geneis
11.3.1 Geneis Company Details
11.3.2 Geneis Business Overview
11.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.3.4 Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.3.5 Geneis Recent Development
11.4 Haplox
11.4.1 Haplox Company Details
11.4.2 Haplox Business Overview
11.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.4.4 Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.4.5 Haplox Recent Development
11.5 AmoyDX
11.5.1 AmoyDX Company Details
11.5.2 AmoyDX Business Overview
11.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.5.4 AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.5.5 AmoyDX Recent Development
11.6 Admera
11.6.1 Admera Company Details
11.6.2 Admera Business Overview
11.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.6.4 Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.6.5 Admera Recent Development
11.7 GeneChem
11.7.1 GeneChem Company Details
11.7.2 GeneChem Business Overview
11.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.7.4 GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.7.5 GeneChem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Trends by Region
2.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue
3.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
3.7 Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Yin Feng Gene
11.1.1 Yin Feng Gene Company Details
11.1.2 Yin Feng Gene Business Overview
11.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.1.4 Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.1.5 Yin Feng Gene Recent Development
11.2 KingMed
11.2.1 KingMed Company Details
11.2.2 KingMed Business Overview
11.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.2.4 KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.2.5 KingMed Recent Development
11.3 Geneis
11.3.1 Geneis Company Details
11.3.2 Geneis Business Overview
11.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.3.4 Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.3.5 Geneis Recent Development
11.4 Haplox
11.4.1 Haplox Company Details
11.4.2 Haplox Business Overview
11.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.4.4 Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.4.5 Haplox Recent Development
11.5 AmoyDX
11.5.1 AmoyDX Company Details
11.5.2 AmoyDX Business Overview
11.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.5.4 AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.5.5 AmoyDX Recent Development
11.6 Admera
11.6.1 Admera Company Details
11.6.2 Admera Business Overview
11.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.6.4 Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.6.5 Admera Recent Development
11.7 GeneChem
11.7.1 GeneChem Company Details
11.7.2 GeneChem Business Overview
11.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.7.4 GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
11.7.5 GeneChem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
Table 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
Table 14. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
Table 15. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
Table 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Yin Feng Gene Company Details
Table 49. Yin Feng Gene Business Overview
Table 50. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 51. Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Yin Feng Gene Recent Development
Table 53. KingMed Company Details
Table 54. KingMed Business Overview
Table 55. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 56. KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. KingMed Recent Development
Table 58. Geneis Company Details
Table 59. Geneis Business Overview
Table 60. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 61. Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Geneis Recent Development
Table 63. Haplox Company Details
Table 64. Haplox Business Overview
Table 65. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 66. Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Haplox Recent Development
Table 68. AmoyDX Company Details
Table 69. AmoyDX Business Overview
Table 70. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 71. AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. AmoyDX Recent Development
Table 73. Admera Company Details
Table 74. Admera Business Overview
Table 75. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 76. Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Admera Recent Development
Table 78. GeneChem Company Details
Table 79. GeneChem Business Overview
Table 80. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 81. GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. GeneChem Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Picture
Figure 2. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Report Years Considered
Figure 14. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2024
Figure 20. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Yin Feng Gene Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 50. KingMed Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 51. Geneis Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 52. Haplox Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 53. AmoyDX Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 54. Admera Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 55. GeneChem Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
Table 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
Table 14. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
Table 15. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
Table 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Yin Feng Gene Company Details
Table 49. Yin Feng Gene Business Overview
Table 50. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 51. Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Yin Feng Gene Recent Development
Table 53. KingMed Company Details
Table 54. KingMed Business Overview
Table 55. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 56. KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. KingMed Recent Development
Table 58. Geneis Company Details
Table 59. Geneis Business Overview
Table 60. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 61. Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Geneis Recent Development
Table 63. Haplox Company Details
Table 64. Haplox Business Overview
Table 65. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 66. Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Haplox Recent Development
Table 68. AmoyDX Company Details
Table 69. AmoyDX Business Overview
Table 70. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 71. AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. AmoyDX Recent Development
Table 73. Admera Company Details
Table 74. Admera Business Overview
Table 75. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 76. Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Admera Recent Development
Table 78. GeneChem Company Details
Table 79. GeneChem Business Overview
Table 80. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 81. GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. GeneChem Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report
List of Figures
Figure 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Picture
Figure 2. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Report Years Considered
Figure 14. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2024
Figure 20. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Yin Feng Gene Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 50. KingMed Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 51. Geneis Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 52. Haplox Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 53. AmoyDX Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 54. Admera Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 55. GeneChem Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232